|
End-of-day quote
Korea S.E.
2026-09-08
|
5-day change | 1st Jan Change | ||
| 3,285.00 KRW | -4.64% |
|
-12.52% | -52.25% |
| Apr. 13 | Genome & Company announced that it has received KRW 6.99999414 billion in funding | CI |
| Apr. 02 | Genome & Company announced that it expects to receive KRW 6.99999414 billion in funding | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -4.64% | -12.52% | -9.50% | -39.39% | -52.25% | +20.99% | -56.02% | -86.50% | - | 134M | |
| -0.82% | -3.57% | -2.83% | +14.50% | +3.38% | -3.71% | +12.92% | -28.13% | +196.53% | 48.41B | |
| -1.29% | +0.85% | +1.06% | +38.93% | +160.29% | +411.90% | +546.06% | +573.55% | - | 45.01B | |
| -3.20% | -0.76% | +8.59% | +41.30% | +14.99% | +38.11% | +18.36% | -1.98% | +233.65% | 44.07B | |
| -1.89% | -2.25% | +0.92% | +30.13% | +15.69% | +2.83% | +80.93% | +1.41% | +1,054.29% | 40.73B | |
| -1.72% | -3.07% | -8.13% | +6.83% | +6.22% | +13.76% | +43.40% | -20.32% | +135.38% | 33.21B | |
| -0.17% | +2.68% | +5.75% | +28.34% | - | - | - | - | - | 17.77B | |
| -0.07% | -0.52% | +0.04% | +30.08% | +5.21% | +21.34% | +117.49% | +204.88% | +1,909.83% | 16.5B | |
| -0.56% | -1.85% | +2.01% | +9.67% | +14.10% | +11.53% | +30.40% | -42.49% | +88.96% | 14.45B | |
| -2.68% | -2.60% | +4.96% | +54.83% | +40.75% | +71.21% | +37.36% | -37.49% | +242.06% | 13.77B | |
| -3.95% | -4.03% | -3.75% | +5.95% | -13.11% | -9.46% | -38.66% | -39.46% | +106.76% | 12.72B | |
| -0.51% | +1.97% | +23.52% | +38.47% | +8.87% | -19.25% | - | - | - | 11.66B | |
| -0.17% | 0.00% | +0.03% | +39.08% | +22.96% | +32.90% | -2.26% | -43.75% | +163.18% | 11.36B | |
| +3.64% | -1.25% | -5.57% | +85.35% | +50.40% | +36.61% | +57.67% | -49.77% | - | 10.37B | |
| +0.19% | +0.62% | -2.30% | +38.77% | +19.59% | +652.36% | +1,531.85% | +4.16% | - | 9.82B | |
| +3.11% | +3.54% | -11.48% | +14.97% | -16.11% | +32.03% | +481.80% | +203.30% | +2,463.45% | 9.93B | |
| -0.78% | -1.97% | +8.32% | +57.12% | +49.69% | +167.69% | +513.97% | +84.17% | - | 9.76B | |
| -2.38% | -6.05% | +0.27% | -23.86% | -28.32% | -7.38% | +40.44% | +51.03% | +88.34% | 9.65B | |
| +0.15% | -1.23% | +0.05% | +49.87% | +67.09% | +141.10% | +677.93% | +200.10% | +1,055.50% | 9.43B | |
| -2.51% | -2.10% | +0.19% | +15.54% | -10.47% | -15.33% | -9.81% | -32.79% | +35.72% | 8.99B | |
| Average | -1.01% | -0.27% | +0.61% | +26.82% | +18.89% | +84.17% | +226.88% | +52.22% | +597.97% | 18.89B | |
| Weighted average by Cap. | -1.22% | -0.15% | +0.99% | +28.95% | +31.20% | +88.92% | +187.35% | +84.52% | +520.39% |
- Stock Market
- Stocks
- A314130 Stock
- Sector Genome & Company
Select your edition
All financial news and data tailored to specific country editions
